The idea for the company originated in a problem Marc encountered in his own research work. There was a lack of devices that were easy to use, affordable and, at the same time, tailored to the current requirements of preclinical research. As there was no suitable solution available, Marc began developing devices himself. Vigilitech now employs 12 people and operates internationally.
The company uses AI tools primarily for data analysis and searches. “We obtain well-prepared information quickly, which we can use to assess the state of the art, for example.” AI has become an important aid to the company, particularly when it comes to searching for existing technologies. “We can very quickly see what’s already available on the market and in what form. This helps us to rapidly determine whether we need to adapt a planned patent.”